无创机械通气治疗慢性阻塞性肺病合并呼吸衰竭疗效观察

目的探讨双水平气道正压无创通气（BIPAP）对慢性阻塞性肺病（COPD）合并呼吸衰竭的冶疗价值。方法对COPD合并Ⅱ型呼吸衰竭患者47例行双水平气道正压无创通气（BIPAP），记录治疗前，上机后2h、1d、3d的pH、PaO2、PaCO2、SPO2变化。结果所有患者经过双水平气道正压无创通气后，临床症状有明显好转，治疗后血气分析中的pH、PaO2、PaCO2、SPO2较治疗前有明显改善（P〈0．05）。结论双水平气道正压无创通气（BIPAP）对慢性阻塞性肺病（COPD）合并呼吸衰竭患者疗效显著。

Transradial coronary intervention of chronic total occlusion lesion 82 clinical research

Objective To explore the bi-level positive airway pressure non-invasive ventilation (BI-PAP) for chronic obstructive pulmonary disease (COPD)with respiratory failure,the value of the cure.Methods COPD patients with type Ⅱ respiratory failure 47 regular bi-level positive airway pressure non-invasive ventilation(BIPAP) ,recorded the change before treatment,on the plane two hours after one day,three days PH,PaO2 ,PaCO2,SPO2 change.Results All patients through the bi-level positive airway pressure non-invasive ventilation,the clinical symptoms significantly improved after treatment,blood gas analysis The PH,PaO2,PaCO2 ,SPO2 a significant improvement compared with before treatment (P ＜ 0.05).Conclusion The bi-level positive airway pressure non-invasive ventilation (BIPAP) for chronic obstructive pulmonary disease (COPD) with respiratory failure has a significant effect.